Genetic risk factors associated with lipid‐lowering drug‐induced myopathies

Abstract excerpt

Lipid-lowering drugs produce myopathic side effects in up to 7% of treated patients, with severe rhabdomyolysis occurring in as many as 0.5%. Underlying metabolic muscle diseases have not been evaluated extensively. In a cross-sectional study of 136 patients with drug-induced myopathies, we report a higher prevalence of underlying metabolic muscle diseases than expected in the general population. Control groups...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biochemical Acid Research Studies
• Share to Coenzyme Q10 studies and effects
• Share to Glycogen Storage Diseases and Myoclonus